CanSino Biologics Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 114.28 million compared to CNY 100.55 million a year ago. Revenue was CNY 114.28 million compared to CNY 100.55 million a year ago.

Net loss was CNY 170.1 million compared to CNY 139.55 million a year ago. Basic loss per share from continuing operations was CNY 0.69 compared to CNY 0.57 a year ago. Diluted loss per share from continuing operations was CNY 0.69 compared to CNY 0.57 a year ago.